Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ-Republic Bancorp shares fall as Q3 profit misses expectations

BUZZ-Republic Bancorp shares fall as Q3 profit misses expectations

路透社路透社2026/10/23 17:31
Show original

- ** Shares of the Kentucky-based regional lender Republic Bancorp (RBCAA.O) fell 1.4% in afternoon trading, to $90.90

** According to data compiled by London Stock Exchange Group (LSEG), the bank's adjusted earnings per share for the third quarter were $1.59, below analysts' average expectation of $1.66

** The loan loss provisions increased compared to the same period last year, mainly reflecting the bank's loan growth

** Including recent fluctuations, the stock has gained about 31% so far this year


(To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Automated translation may contain errors or lack required context, so Reuters does not guarantee the accuracy of the automated text; it is only provided for the convenience of readers. Reuters assumes no responsibility for any harm or loss arising from the use of automated translation.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks